TYPE XII COLLAGEN AND PERIODONTITIS
XII 型胶原蛋白和牙周炎
基本信息
- 批准号:2634126
- 负责人:
- 金额:$ 8.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-01-01 至 1998-12-31
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay antibody cellular pathology collagen complementary DNA disease /disorder model fiber cell gene expression gingivitis immunofluorescence technique in situ hybridization laboratory rat messenger RNA nucleic acid sequence periodontitis periodontium polymerase chain reaction protein degradation protein sequence protein structure function synthetic peptide western blottings
项目摘要
The long-term research goal of the proposed project is to understand the
pathophysiologic mechanisms of progressive connective tissue breakdown
widely experienced in gingivitis and periodontitis. Type XII collagen
is a homotrimer made up of alpha1 (XII) chains and found to be present
in the periodontal ligament, and in tendons and ligaments, tissues which
predominantly contain type I collagen. This molecule belongs to a
recently found group of collagens that represent minor constituents of
the extracellular matrix and are referred to collectively as FACITs or
Fibril Associated Collagens with Interrupted Triple-Helices. The tissue-
specific expression of FACITs and the characteristic heterogeneity in
their amino-terminal domains strongly suggest that FACITs may play a
significant role in organizing the three-dimensional spatial pattern of
collagen fibrils in different tissues. As described in Preliminary
Studies we have shown that the expression of type XII collagen is
significantly associated with the rat PDL and dentogingival fiber regions
during the maturing stage. In the healthy periodontium, the
dentogingival fibers are arranged in neat, parallel bundles. During the
initial stages of inflammation each individual fiber maintains its
integrity, but the parallel arrangement is disrupted and the fibers
appear dissociated from one another. In this application, we proposed
a hypothesis that type XII collagen may be degraded first in gingivitis
and periodontitis, leading to collagen fibril disintegration. This
molecule may therefore play a significant role in the pathophysiology of
progressive periodontal tissue breakdown.
As the first step to test our hypothesis, the expression of type XII
collagen mRNA will be studied in a well established periodontitis model
in the rat. Next, the primary structure of rat XII collagen will be
analyzed by molecular cloning and sequencing of rat alpha1 (XII) cDNAs
using a primer extension method. The DNA sequence of alpha1(XII)
collagen cDNAs will provide deduced peptide sequences based on which
several synthetic oligo-peptides will be prepared. The synthetic oligo-
peptide will be further used to generate affinity purified polyclonal
antibodies against rat type XII collagen. Finally, studies of
immunoblotting and immunohistochemistry will be carried out in various
stages of gingivitis and periodontitis using the generated anti-rat type
XII collagen antibodies.
The findings from this project will provide the basis for better
understanding of the specific pathophysiologic mechanisms of periodontal
disease at the molecular level. Furthermore, both cDNAs and antibodies
recognizing rat type XII collagen mRNA/DNA and protein, respectively, can
potentially serve as significant tools to investigate the aspects of
aging, response to infection, effect of systemic diseases, and genetic
disturbances on the periodontium. These studies will serve as an
important background for human disease.
拟议项目的长期研究目标是了解
进行性结缔组织破坏的病理生理机制
对牙龈炎和牙周炎有丰富的经验。 xii型胶原
是由α 1(XII)链组成的同源三聚体,
在牙周韧带,肌腱和韧带,组织,
主要含有I型胶原蛋白。 这个分子属于
最近发现的一组胶原蛋白,代表了
细胞外基质,统称为FACIT或
原纤维相关的胶原蛋白与中断的三螺旋。 组织-
FACIT的特异性表达和FACIT的特征性异质性,
它们的氨基末端结构域强烈表明FACIT可能发挥作用,
在组织三维空间格局的重要作用,
不同组织中的胶原纤维。 如初步说明中所述
我们的研究表明,XII型胶原的表达是
与大鼠牙周膜和牙龈纤维区显著相关
在成熟阶段。 在健康的牙周组织中,
齿龈纤维排列成整齐的平行束。 期间
在炎症的初始阶段,每根纤维都保持着
完整性,但平行排列被破坏,纤维
似乎彼此分离。 在本申请中,我们提出
XII型胶原可能在牙龈炎中首先降解的假设
和牙周炎,导致胶原纤维分解。 这
因此,这种分子可能在糖尿病的病理生理学中发挥重要作用。
进行性牙周组织分解。
作为检验我们假设的第一步,
将在良好建立的牙周炎模型中研究胶原mRNA
在老鼠。 接下来,大鼠XII胶原蛋白的一级结构将是
通过大鼠α 1(XII)cDNA的分子克隆和测序分析
使用引物延伸方法。 alpha 1(XII)的DNA序列
胶原cDNA将提供基于其的推导的肽序列,
将制备几种合成的寡肽。 合成的寡-
肽将进一步用于产生亲和纯化的多克隆抗体,
针对大鼠XII型胶原的抗体。 最后,研究
免疫印迹和免疫组织化学将在不同的
使用生成的防鼠类型的牙龈炎和牙周炎的阶段
XII胶原抗体。
该项目的研究结果将为更好地
了解牙周炎的具体病理生理机制
分子水平上的疾病。 此外,cDNA和抗体
分别识别大鼠XII型胶原mRNA/DNA和蛋白质,
可能作为重要的工具,调查的方面,
衰老、对感染的反应、系统性疾病的影响和遗传
牙周组织紊乱。 这些研究将作为
人类疾病的重要背景。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A new animal model for molecular biological analysis of the implant-tissue interface: spatial expression of type XII collagen mRNA around a titanium oral implant.
用于种植体-组织界面分子生物学分析的新动物模型:钛口腔种植体周围 XII 型胶原蛋白 mRNA 的空间表达。
- DOI:
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Karimbux,NY;Sirakian,A;Weber,HP;Nishimura,I
- 通讯作者:Nishimura,I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NADEEM Y KARIMBUX其他文献
NADEEM Y KARIMBUX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NADEEM Y KARIMBUX', 18)}}的其他基金
MMP EXPRESSION IN A NOVEL IN VITRO WOUND HEALING MODEL
新型体外伤口愈合模型中的 MMP 表达
- 批准号:
6011651 - 财政年份:2000
- 资助金额:
$ 8.4万 - 项目类别:
MMP EXPRESSION IN A NOVEL IN VITRO WOUND HEALING MODEL
新型体外伤口愈合模型中的 MMP 表达
- 批准号:
6379881 - 财政年份:2000
- 资助金额:
$ 8.4万 - 项目类别:
EXPRESSION OF THE PERIODONTAL LIGAMENT MATRIX GENES
牙周韧带基质基因的表达
- 批准号:
2129123 - 财政年份:1993
- 资助金额:
$ 8.4万 - 项目类别:
EXPRESSION OF THE PERIODONTAL LIGAMENT MATRIX GENES
牙周韧带基质基因的表达
- 批准号:
3036002 - 财政年份:1992
- 资助金额:
$ 8.4万 - 项目类别:
EXPRESSION OF THE PERIODONTAL LIGAMENT MATRIX GENES
牙周韧带基质基因的表达
- 批准号:
3036001 - 财政年份:1991
- 资助金额:
$ 8.4万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 8.4万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
Grant-in-Aid for Scientific Research (B)